Earnings call transcript Q4 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good afternoon everyone and thank you for joining OptimizeRx’s Fourth Quarter Fiscal 2022 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, Will Febbo. He is joined by company Chief Financial and Operating Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva.

At the conclusion of today’s earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today’s call. I would like to remind everyone that today’s call is being recorded and will be made available for replay via webcast-only. today’s company’s and website. in section the included the of are press in release Investors Instructions

understanding financial In financial GAAP press they the release. measures management financial today the addition, will found that believe discuss measures can aid in to A reconciliation results. certain be non-GAAP of comparable company's today's in

Now, OptimizeRx Sir, Febbo. ahead. CEO, I’d please to the turn like that, William with call to over go

Will Febbo

XXXX Good afternoon and today everyone and call. for a you been us fiscal much new of challenges operator. thank for our OptimizeRx. joining year our industry you, earnings for great has XXXX and Thank of opportunities

During the temporary our volatility, consolidation year, market within we saw sector. amount of and a enormous headwinds, an

our financial its maintain evolution. business continue to While its as to footing to and also impacted headwinds topline of results, ability strong our pharmaceutical digital we accelerate industry the continued resilience saw the

platform. parties, health directly This multiple the the clients, opportunity created company shift digital tectonic the partners, clients, adoption OptimizeRx's patients. and doctors, unprecedented by believe in in interest towards strategic use with aligning to from the I of this technologies and our and correlated is

our XXXX's range. fell revenue within revenue of million $XX.X guidance

were high $XX during margin surpassed gross XX.X% and generate of year. million the to the of guidance, our we in Our operating flow able nearly end cash

and for into and number will limited measure well-positioned health our I given industry. growth but can the the are go who more we the team, Ed the of in the shortly, financial of maintain details report scale, of players business,

data to utilize in still headwinds the calls, despite outlined win our or we deals offering. able macro importantly, six More RWD-AI that previous AI-driven Real-World we've were that

this believe increase in XXXX. this continue to RWD-AI solution year-over-year XX% least of to year XXX% revenue expect revenue have additional total approach and wins will our We at and from

by our we also our to least improvements in to which and a for should XX%, As end. are drive looking increase year's topline see to favorably KPIs positioned growth are revenue XXXX at result,

positive optimistic the year, While trough, begin the as guidance despite conservative years. are headwinds backlog given backdrop subside we are compared trends to start macroeconomic the since the that macro more will to of a the revenue been at mid-XXXX year higher approach a year this this we to have there previous then having taking

technology building ROI single-stop expanding tuck-in and for our offering Operationally, investments, small awareness made have we acquisitions also on solutions. a partnerships, reputation that industry serve. brands a our driving and progress created of We've in superior the tremendous robust that's omnichannel our

business workflow we model the the to continue care largest solutions are that able to connectivity digital the network prescribers. manage US Part of is special makes and fact deliver our this to in what point via of in

have result capturing this, which greater available five three expanding of us years. to been the white industry the we portion To believe in service outside complement of EHR, will over we offerings space a next the

total which industry more than even currently billion brands we fast, With we space into are working. white the for remains the which $XX in and growing, digital with sell at spend

entrants. And new we to been vendors. From willing managers a brand what functionality being new the of are out well witnessed we competitive have perspective, of aware intelligence has test

new in which longer this trial ecosystem end compete. the being result short is a from the entrants cycle out after While XXXX, in weeded a sales create did quickly period, we that are

lacking HCPs is patients. issues have and address which facing enables and entrants been meaningful than to really interoperability, our Initial prescription less solution evaluations offerings us fundamental connectivity and foundation platform of the stellar due to of new

clients industry-leading our As with to recently by to with as market an a with established complexity, provide with capabilities coupled along in point-of-care reporting insights, partnership shifted exclusive investment our MMSI, demands continuous enhanced grow supported continue of solutions, adoption priorities data-enabled actionable agency.

of portion their greater is digital pharma toward commercial a omnichannel spend Meanwhile, solutions. moving

While patients patients new identifying also the known to for HCPs, pinpointing therapies. to solutions impactful looking but only more for not deliver by results these

with solutions, reallocated the digital. smarter dollars such particularly of believe that commercial the RWD-AI as We legacy to our lion's offering, will are spend, pharma capture share

ability trend We the this was believe deals is pharma early clearly tightening first of highlighted proof six by bottom-line. win to their preserve to its strings our when time RWD-AI during year-end

a obtaining streams benefit us greater has overall RWD-AI stronger of pharma growth moving from margins with we by can and partner a added to while a with benefit top-down the where stickier being from revenue tactical strategic bigger push a potential. player decision-makers,

I of in strategic today. our significant is That sits. next positioning I've our multiples over expect revenue years impact where why dividends today excited about I combined five result outlined the to pay currently more increasing it three than what of I've am and the to been never to

For following through now, strategy. land-and-expand our we are with

traditionally to continue on well considering superior This sought to the at of stand to ratio our over XX:X. spend. three We which continues benefit delivery has is significant of from ROIs return times investment, two of pharma a

I'd the Ed? details that, CFO QX. us the over With and financial will for turn through Ed to COO, like who walk to call our Stelmakh,

Ed Stelmakh

Thanks and good afternoon Will everyone.

release can from our all with in available section be the with XX-K, of ended to viewing be may be copy our was additional Investor will quarter A As forthcoming obtained and website, filed XXst, December our results the for coming of days. fourth information is our which downloaded and calls, issued the XXXX. the press Relations

the results Turning to our fourth financial ended XXXX. XXst, quarter December for

year of end from the for revenue $XX.X million, its the strength was period a biopsy. as during recognized we in same period $XX.X tightened X% reported million XXXX pharma decrease around the of Our first

quarter the The the partner result solution channel period. increase margin Gross of a favorable to reporting from and gross current period the is margin XX% ago in the year mix. XX% in for increased

in guidance XXXX gross continue We XX% solid XXXX XX%. margin for and to gross margins full expect our year coming calls our between and

year ago approximately OptimizeRx the is to enable increased team period. same investment $XX.X the our quarter compared which This fourth expense also acquisition $XX.X April due fiscal the future expenses in of EvinceMed. increase million XXXX the to as in Operating to in million in growth, of includes approximately to primarily year

million OpEx, year-over-year expense, the stock-based the related the our $X.X primarily was to Providing increase EvinceMed with non-cash more million being to of color around acquisition. remaining and compensation amount tied of $X.X year-over-year increase

We had XXXX fourth quarter compared of to period of the of in in loss $XXX,XXX a fiscal net a during income as same the $XXX,XXX XXXX. approximately net

results, XX-K. For further XXXX upcoming fiscal details on of our our the MD&A to can section you refer

of of the year On same XXXX the $X.XX or approximately as basis $X.XX a fully $X.X non-GAAP on to income fourth a $X net period. million compared in diluted income quarter basis, or net ago per diluted was a approximately fully non-GAAP million share for

$XX.X from $X.X during flow generated cash in XXXX quarter. the also We fourth million and operations million during

as million was equivalents, December sheet compared XXst, our million and in with our balance remains investments as as short-term sequential buyback. September XXth, of XXXX, strong short-term Our to cash, cash investments totaling equivalents, $XX.X and decline tied XXXX. cash cash, of $XX.X The to

quarter reminder, bought the million XXX,XXX a an of quarter, we As back $XX shares million $XX.XX. we the for price a and announced during $X.X during share program fourth second repurchase at average

to our nearly amounts positive per repurchased total price shares This our X.X of million shareholders. $XX.XX share. total, In net at XX.X an for reduction outstanding XX.X X% in million a from shares to average a million, we

quarter at revenue in million, year we to year-over-year for least expect the first $XX.X the to our between $XX terms revenue and expects In of full XX% of XXXX, outlook come increase million. company revenue

turn let's our to XXXX. Now, KPIs for

and average rates revenue as by million pharma the XX% $X.X turnover a for world. as higher decision-maker extended XX deal nearly manufacturer timelines top in year-over-year result post-pandemic Our pharmaceutical well to ranks the declined of as closing

commercial pharma XX% resulting macroeconomic of Our to XX already adoption within the factors global to the clients. remains of on revenue the declined strong mentioned also pool Net rate companies XX and be retention due the programs. pharma several most top client meaningful impact our with continuing

per Our with operating of resilient coming at remained challenges has $XXX,XXX. revenue face the FTE in XXXX in model the

KPIs and OPRX's a the a our in XXXX. to to our communicate progress manner. similar consistently land-and-expand transparent fashion Our to to report stakeholders intend capture strategy continue in results in We continue of

to Will. Will? like call And with to the turn that, I back now would over

Will Febbo

Q&A. let's Operator, move Ed. now Thanks to

Operator

Thank and begin Instructions] question-and-answer we [Operator the will you. gentlemen, Ladies now session.

Your Blair. first Daniels from Please go question William Ryan with comes ahead.

Ryan Daniels

Thanks I'll QX you QX, outlook. expect and XX% XX% questions. Maybe year-over-year the a based guidance year, looking It looks of drop in like in for a but on the with on you for for full start revenue the question about Ed taking still growth. the revenue year-over-year

to the So, year can bit speak little the throughout the you cadence a ramp? of revenue and

Thanks. to that kind maybe what's some or of getting And signed then any commentary the year kind of conviction growth there? kind slower help there, to you start and on in given in you XX% -- triangulate backlog visibility have of getting plus of, implemented us the to given be level the

Ed Stelmakh

Great Ryan. thanks Yes, question.

of as So, in, concerns, as vast as our of comes know, the far of in second the the half cadence revenue year. you the majority

a hoped stronger we than we're coming with backlog little weaker a out had RFP that's So, season the we the had yes, bit mentioned. QX in is as than had for. definitely Will past, of But

get XX% and line will on have us opportunities least is towards now of will definitely at a growth We continue desire our that plan their it our back more the year. to feel backlog. the right really So, end but this build to year, we rate to of do to see sight

Ryan Daniels

that contracted for versus have or to out How XX% market backlog much win a of that just volatility get such to a you go kind I'm is could there worsens. trying basis contracted. how much be of really macro already and the growth on on is in something the view

Ed Stelmakh

Yes.

forward year. every of XX% year range numbers. Typically, of the looking I So, XX% disclose for rest the sight we it, year we specific call QX sit line is in and of and every don't between, where between would

our XX% into year. line that sight somewhere rate for So, going this is within range of growth

Ryan Daniels

there's I Thank on the forward a And but a engaged on they is actively KPIs, dropped actual the timing out, during weren't an partnership one is then but the just lost know partner, go basis? Okay. it as that still the could period, be partners where you. of or

Ed Stelmakh

churn of client certain smaller really it's drop but we part normal clients. out, not had within a the Yes, one of portfolios

small So, we was generating a that's cycle. that of just amount revenue the had of normal client part one

come out, within any our clients declines. no solutions drop of services sometimes in, come will Sometimes and they in but real will there's

Ryan Daniels

Okay. That's macro what question for And thought. Will. I a maybe

engaging on to know, view with in providers the Just digital what at you do regards in solutions. you market point-of-care, the pharma's see

know mentioned force, care shrinking You I ROI. marketing? their view broadly the the but on sales own pharma's XX:X what's

Will Febbo

That's whatever people sign. Hey MLR It are you've pharma. Ryan. or delay say start Whenever just that you sometimes taken use or I services infrastructure the can questions. And legal review the is That means that see selling that a well seriously. very you from the heard very term marketing. within for pharma positive would to being Thanks is sales as I think But companies one. it means cycle other launch. that in

been just there's over of built trying Two, a very leading pharma getting and last a at heavy and in so the XX companies much can is to that the good lot months, scale awareness of there. piloting, lot

the can't won't the if away you have, have, be on we well, -- based do for you it the based is at at just just a scale, the cluttered way in trust the going XX because it So, of it start the we That we've that relationships got with is for built, won't par report, on team type clutter last excellent fade months that conversations you we said delivers to table. and post-COVID. to yes, pharma,

well, conversations those has and table more. net-net, are they're all us say, would anything back for really with we've and that to-date done going I performed at So,

world So, their still with on interest back hikes. still and slowing, headwinds we're is the rate obviously, feet, have internally, dealing FDA is turnover net-net, macro good macro getting still the their

Ryan Daniels

And then question. final Yes.

front mentioned curious the offer a specific impacted? vision solution product increasing the any You that there competitive and I'm cycle. elongating was was you if

fair of a been have as think perhaps a anything XX:X to that that competitive flip ROI, could the then been savings Thanks. And produce, you they it able but that validate hear to you to don't in to level know heard I if so the we future? anecdotally your statement, back two. that's love haven't follow-up, what those about they've environment on and if like able sounds of

Will Febbo

Yes sure. Thanks Ryan.

relationship. the things. the don't but On two like not of talked ones we by directly the going the about pieces, have network to do. always competitive And we've competition, a have come to different other front, integrated, X most connecting that the reach it's really that's various full They're in Tier of do

of someone, that That's going you're not someone you're to some to going them your you going it through really may on to question, lose data all. -- that's just measurement because limit to going going or who's second and through when -- at get

the think noise. we've seen. what been That's I that's So,

And you time. on for are agencies pretty new all heavily to agencies pharma relies and remember have the looking that solutions

has and So, in lot last try a the to market the XX hit months, they it. want

it data set, response So, do year, none last still the working on just net-net, see unique others been especially being we've that which itself from through, a of tremendous. while layered has the a clear and RWD-AI, path pretty crowded client was we can to since

it's that think And ROI. I have pretty generally actually and of integrated, But measure the very straightforward help ROI a they for that So, to will given on strong our how the cover, do. can it. other us companies ones some have us do -- scale, that that are those you ones, we they

Ryan Daniels

comments. Okay. Perfect. for the Thank you

Will Febbo

Ryan. Thanks

Operator

ahead. Dodge with Capital from comes Please go Markets. question next Your RBC Sean

Sean Dodge

afternoon. Good Yes. Thanks.

maybe just you call. just back in said us to XX% RWE some to reconciling the guidance, the from you could give you grow Will executing help then over opportunity going to the XXXX. position statements the QX Just on if

based you're appears on It but guiding it than what XX%. to you've executing on less announced,

So, of is kind RWE attrition situation cannibalization offsetting ongoing it that's -- the the macro also you there the of is mentioned? this of that's just or happening kind difference is some positivity the Is front? the the on conservatism or challenging

Will Febbo

late be gone, economy conservatism. being that's the Yes. put the other mostly No, think two And you the enough right? said, to we hard to report it's and a think I to conservative. I exceed, board, our also, So, completely people goal. as it's we can We together better why and headwinds listen work have. executives it's across aren't macro and that's conservative in we that the enough and real lot And are

Sean Dodge

Okay. are guess, this pipeline those existing are Can now several net to dozen And RWE made that I deals. about looked looking clients sense then last contains several prospects? like of said what pipeline, upgrade or largely dozen give the you opportunities, year? us a new the comments maybe RWE time then you to And you these, these

Will Febbo

let we have Yes, just remember, I'll a last answer pipeline this start, well. year. then as didn't I'll time and But Steve

into doing RWD-AI. XXXX. new do those either little were is pipeline ROI color measuring another or had had projects existing clients XXXX we bit done then We two back want So, And come in we this a four. to to generated all in players largely you and and about getting Steve, the give more talk clients But that?

Steve Silvestro

Hey to. happy Yes, Sean.

for one got of we've I really team think of the things of that's are is, patient this have us people who've architecture. that are MDs the clinical and driving driving got two which clinicians, solid experience a practice,

So, that's differentiator. really unique a

involved people that so are And are these existing with clients.

taking work being we're of on XX is this so that then and doing work done most the they're it. in adding to So, top and

driving it. the So, land-and-expand on it and early enhancing we is strategy that implemented

right? and much So, is portfolio of same to solutions cannibalization, no implemented. that different This opportunities sort maybe the on but brands, additive some already the are logos clients, larger completely

Sean Dodge

The there then great. one, of maybe of like and I signed of beginning for were new QX last captured QX just deals revenue Ed. maybe or that associated in implementing process kind RWE any XXXX? this with incremental in fees And now, the in of architecture or we're all that’s is you've presume net those, was Okay,

Ed Stelmakh

Yes.

design that again, QX and architecture are was some but from that So, were there six revenue projects there fell into signed.

within captured year. more So, it will before, wasn't get there's all that so converted this

Sean Dodge

great. Okay, again. Thanks

Will Febbo

Sean. Thanks

Operator

ahead. next Stephanie with comes from Please question Davis go Your SVB.

Stephanie Davis

you wins my fueled question. XX% Thank growth you alone. a last guys. taking that quarter, by pointed Will, Hey RWD-AI revenue for

little XXXX surprised a outlook. we're by obviously, the So,

kind me pricing attrition? drivers in out of the faked we just is what client walk quarter, that the market guidance. a that called of Is the to that this you decline implied or Can talk is of and assumptions-wise? shrinkage, And So, you wallet approach something about to through in else? kind conservative

Will Febbo

QX-- your hear Yes. voice. Hey good to Stephanie. In Sure

Stephanie Davis

Right. back. am I I Should leave--

Will Febbo

way. No No.

headwinds, the You'll way. year to in talked growth we we've about. look, we said which we're it. about QX, could if great up seen we our No, everything not continued only And bring -- ones it talking the We've get went together. frankly, XX%

thing. not new it's it's like So, a

not make And which more on We're solutions, a better We're conservative, client. so strategic more right? pull that's other closing going us basically losing for deals with the in the make solutions, to new clients. which relationship

The what clients table. maybe like the from as us digest to a I'm a it. to decisions decisions, are we're I clients true little being And peers. one younger few think of little And I And -- when of or be think agile faster. more the to actually, with It's I'm taken brother make longer that's bigger. for the but at and them their smarter going it's a

points have hard our The hard They programs, can HCPs. still have time a a enabling reaching do have that time patient a They pain exist support for that. clients. we and network

So, to confidence a And build no can being here, year way. we we good be want up a of drama in that the that. do lot able have conservative, to

Stephanie Davis

All right. Understood.

this put me way. Let a different

did of that something is read a what's that or we more hopeful we guidance You move? should the on ahead massive macro else in view consider implied this in buyback Should there's the guidance. a as than

Will Febbo

I did also but too. the the company's team Yes, buyback not money, a a we senior did only with buyback, think

leaders, I in unemployment the where So, should we market highlight our and that it had we've company. turnover the obviously solutions this get of new even good choice and everyone is in amount no Look business. has with need

you smart to and requires what do. a a being I be and to share mean that lot us. Stephanie, got everyone conviction careful doesn't more tell in a that smarter with going all they a we've we're lot that But lot that's telltale not on So, you that with a that hitting of we're which market everyone think is

our So, year. keep drivers going to the we're We're focus going on updated to that. on through everyone growth

think the to thing I that's as an investor. watch

solutions good the at look at see types of that. we're don't of traction this none to other -- we're them I my getting there going generating all, if are in some client in of trouble any back You're because size cash helping no at financial different mean, and you sets peers, growth around we business. doing

feel spot. of like conviction. in Lots great we we're So, a

Stephanie Davis

it. Appreciate Thanks. good. All

Will Febbo

Yes, talk to you soon.

Operator

Your David Please with Grossman ahead. from Stifel. next question comes go

David Grossman

Good thank you afternoon and much. very

other questions. out think this few has a I So, been coming

I just of So, just sorry But just well. looks understand first helping and financially, architecture fundamentally sense was rate a retention the maybe was? question fundamentally as this what of is I'm XXXX, It it's to the underlying revisit not better down this. get just guess to just the better being your year. I hoping us dynamic like but with thinking

underlying roll And one terms it, in of so I then to were you retention, it as if revenue get at kind to hit XX%. base, that to or that covered looks in of other you the your And didn't was quite add drop but why like $XX your questions, apply what guide sorry about this there a million if drivers? you forward, in big least such the of got for you

you the already that cadence signed, RWD-AI bookings going of deals that kind cetera. fees the in how new in you're get would of want much from ordinary that you've et to And the of how do fees of and business about think architecture to to from us fall terms

Will Febbo

do questions tackle of A in to want you couple one first. Ed, Okay. retention there. the

Ed Stelmakh

Yes.

Will Febbo

The KPI.

Ed Stelmakh

David. Yes, great question

XX-month are to know, look months you trailing back. as KPIs, the So,

year. which very obviously, the versus with full XXXX, impact XXXX, of a that the in stellar now less So, strong year capturing year than had we're

comparison that is year-on-year dynamic. basically skewed So, by

gets -- metrics you that year those on the better, see XXXX see in obviously, and as metric. you the impact should As recovery an

David Grossman

one, on kind half of that think much go And Ed the next in about losses happened it because if that as just were year? year next towards the beginning the don't as you to was wondering things at much thinking the you in I year retention by before went right had think how I of some versus of wondering you driven -- XXXX. earlier in the as your year, number year terms those of all, just I but the on the the know if about just if back changed and mind

Ed Stelmakh

pool were that a of detail that year factors good of don't I if just really in It a several that revenues of I role kind down occurred probably know of last disclosed. we was that those to terms quarters. clients. there mean get within confluence level of dynamics played in we XX all underlying driving Yes, that already top

see, of But that hits of that as see bulk We grow, decline did portfolio you'll XX, metric top within you outside to the the driven the since degree. some that pool of clients. can

David Grossman

you. Got

Will Febbo

of to of Yes, year -- the going Yes, of last the into question, how second David. ordinary. a revenue this projects were for is but growth year. much additional this that year sort part had also It's be to of growth, we that clearly, your is RWD-AI piece pushed

part that already So, is and of rolling. that's that as well

well And of then some as just have as advise we RWD-AI and there seeing, agencies talk given it's one don't We're last the we number, marketing the said, we've -- about among big we pharma the differentiation direct-to-pharma. year. pretty did a pipeline We but didn't building. as just aggressive that also,

have it. us actually of It's the measurement not gives on It's in just closing that to now year toolshed offering the shiny because object. this against we more part confidence kind put of of So, now. a

combined XX% least should things that the additional for needed give growth. those revenue So, us at

David Grossman

provide or Got all, year-over-year off but information, just business at we've at a just either one that you it. may look got your And patents, if coming favorably you last unfavorably? this if patent can't qualitative -- I impact remember just one. whether drugs

Will Febbo

do have this something year. other not Steve, on dealing is not Yes, it's to comment that, our one you any this headwind but -- we year, that do not it's we have we're material with revenue. a

Steve Silvestro

not programs that than more larger us of year this several expiry. significant And but sort a they're expecting impact year to and next all, couple year, we're negatively the Yes, will programs. at launches current on patent latter part be nothing next of

something at. So, great we're looking always question,

David Grossman

Thanks much, very Great. good guys. luck. All right,

Will Febbo

you. Thank

Operator

Please Your Neil with Riley. go Chatterji ahead. comes next question B. from

Neil Chatterji

Hi a guys, lot questions here. but thanks good maybe there's guess afternoon already questions. just you one of for taking fielded guidance, the and our I on more

Just the as first of guess, second the I think the of RWE half? potential the we or half incremental just cadence about -- kind deals, into

and you the and that's the that acceleration half? color that topline on in provide contemplated for guidance how present if or Any can in could your back upside expectations some growth maybe

Will Febbo

I'll overdependent Yes, the and on growth Steve. traction. news it on on not We're then is new start pass I'll it's either, But right? the showing that to something obviously in good that's not and going all

potential you Steve, there's to some So, of there year. view. cadence to through talk from the it upside But my do sort want of the the

Steve Silvestro

happy Yes, to.

pretty heard from is Will portion of our robust this As pipeline Ed, and particular for portfolio. you've the

so the we quicker architecture. the we recognize these can the sooner close deals, And

So, and the the first component messaging by architecture is driven model. the

the So, more we that revenue launch, they sooner the can recognize.

already closing In additional six of first of And out deals. good will that, RWE some have in pretty think look live. terms you've terms of the heard half we clocking the deals, I from

So, continue of remainder those throughout the will the year. to generate revenue

messaging of because being the by will higher be more volume, targeted. the frequent driven course, And more models, they're but

So, hopefully, of more that a components. you bit two insight gives little

Neil Chatterji

time? just capacity overall update of helpful. -- on if an maybe I platform's you just this curious at it. just give if the could And Got was us That’s kind

Will Febbo

overlaps tremendous really it and complicated Yes, And reach connects a to no HCP reaching focus on problem. the six that the that We talked job done out we've lot -- to with hardest spent specialty expensive pharma years about that. finds it we've a channel. physician patients. for and last We medications, are which obviously, building five,

we of is right than Now, less is utilization have probably used still. now underutilized in access. terms actually more It's far XX% capacity that our than

on good it's going bet more one to incrementally, any add past. to is dramatic the execution this news commercial they years big be partner. That won't have not play as mean don't partners, as doesn't we're on We a but year. So, any one

also the channels. so And expanding our focus other we're on

So, omnichannel, right?

point-of-care, track of the them where let's and and deliver to social, when places a see but just actually think think not they're all measure. let's we physicians of information can physicians Let's and other are,

lots it's approach and utilization in coming net-net, to our of XX% this omnichannel just channels So, market new the of under rather year. capacity and terms

Neil Chatterji

Great. in one sense spend us can of headwinds the COVID And here just how one expect mostly? rearview year then kind of with you thinking of for maybe here Maybe kind of digital how a the you if kind in or me. just last to marketing our give you're trend and

Will Febbo

Yes, Steve, do talk you to that to want one?

Steve Silvestro

Yes, happy question to. Neil. Good Thanks.

So, look, is the leaning manufacturing digital spend. I everybody think board that across university into more

a sure I will or think guys investment. been we've have seen announcements hit. of of field started those hit Most to bath force them. you I'm ratcheting have tracking

years As Will said, meaning a in has the is environment of bit past. XXXX year, this cluttered little more it been into than digital spend coming XXXX,

get on of that's jumping entrants in space. to think is board. everyone because I small largely it saw such lot of sort trying an attractive We had new a

for of that those requirements now players and sort are established hitting. reporting other news OptimizeRx good The is

that these not turned the off And in so programs are competitors. smaller are getting delivering

the And news stable like good others. so companies think, for I that's, OptimizeRx and

in terms not more where doctor it's of leaning the which they terms but wherever the definition Will you in as they now what see are. in lot think the EHR, that more are, I heard just point-of-care, and leaning think of doctor, they information as Ed the companies the following I We as is this well, point-of-care said, then say giving is. general in a And need, expanding into to

on. something omnichannel is so And every that focused manufacturer is that play

And it's pretty best data-driven. that action is the communicate module a phrase that's frequently. next really where a manufacturers hear action You'll used probably looking with should at next and the as physician

an the in in of that's business that's only got terms way. place and good because really to right we're a integrated that in real a drive point-of-care the model action We're RWD-AI to expect at that now, ability use

question. you So, position Thank it. to it's for in, a good but excellent be

Neil Chatterji

Thanks. That’s it for me.

Operator

Martinuzzi question Street. Lake next from with Please go Eric comes ahead. Your

Eric Martinuzzi

of Yes, to a the ago. QX third on just row in the on February focus But for to would the a versus February I kind contracting. with XX% January, That I January, year your wanted quarter. wanted outlook be quarter about here midpoint down focus

Anything year, year on -- much I you -- versus the just would and February, buyer topline, in obviously, those think a out well, finished maybe the year, but we you the behaviors thought ago? came in what do different is -- about the how -- January pretty QX guys because entering the anything you

Will Febbo

Steve, to you do want start?

Steve Silvestro

Hey little in to of terms of the issuance. no your good did hear a Yes, of voice. We gate Eric, out see slowing RFP problem. bit

they think of were to I where wanted sort submit RFPs. manufacturers on aligning

saw seen past. we years that, said we've in a Having than of plethora in more RFPs come

initial buying as this the clocking optimistic view. full an signs, positive, little us So, a is But are on pushed bit to year of out. that you've very call, of the heard kind leading

heard a think we've that's of we're the talk where at. backlog, shared I about optimism feel given that You degree we us universally probably which

And year. full so that at in with as just QX our of and but our sort performance, it of not [Indiscernible] guiding the looking projected here terms we're year on using

Eric Martinuzzi

this like Okay. in the of the uptick of into January, February, baked February any XX% beginning the March kind of that But quarter. minus is end or as there of an

Will Febbo

We generally--

Steve Silvestro

Go ahead.

Will Febbo

It's Steve. go No, okay. ahead,

Steve Silvestro

form that the say already of done, quarter of I we've revenue of going guidance terms the and we've what success. we looking recognized we're outside got think on components Eric. a we're to what at, forward-looking But I in not two right, we as mean can Yes, give report sort backlog of

to know we I you Will, add we what else? say if so And I can anything that, said want on think don't

Will Febbo

partners that we're it everything of in will the it through and is rushing agency of Yes. seeing much say surprise at we're it looking seriousness going I seeing, given our the have it engagement. seeing on. just I some No, year me think we're But lean level not -- through bigger through that we the seeing at pharma we're that's right. RPs, And backlog, doesn't conversations, what

So, there telltales yes, are Eric. just to one, good the trying for be this conservative Again, on a really year.

Eric Martinuzzi

for Okay. expense about about QX expense what think we talked QX? And you should million, I was then, $XX.X operating GAAP Ed, operating the think -- for

Ed Stelmakh

Yes.

Thanks got I Yes. -- So, Eric. it.

hired for the are year. impact a fact we is we obviously, few will you XXXX. will tell operating that But given bonuses our be year full So, that can probably guide don't what we FTEs There a an just be of expenses. in I there the uptake, on setting

be two And investments But run of any We're in of contained. an speaking, the part not generally the us factors certainly bit earlier will give year. I think major to a those the probably rate pretty expecting uptick.

Eric Martinuzzi

Got my it. taking for questions. Thanks

Will Febbo

Eric. Thanks

Operator

[Operator Instructions]

proceed. further are There time. Please questions at this no

Will Febbo

Thank you, operator.

So, we're a better truly in an the industry entering paradigm and that drives and technology way patient is enables outcomes. shift care generational in

promise That industry improved no we change, the and from RWD-AI. strategic from the our said, additional require longer run I utilizing the tactical for deals particular, in as move given of truly buy-in we businesses stakeholders. which closing rate of are line say larger deliver with in on to a platform increasingly the this are growing In our value. have outcomes, our this deals, importance right to solutions, place believe that in backdrop,

also We've company, ROIs outside our clients, for built Moreover, our driving the services and we are and us partners, a our advantage EHR, robust distinct as gives strong a portfolio continue and competitive a culture on expanding as outcomes improve customers. focus team investors. our which omnichannel of we to patient the while of

next the In our distribute XXXX, the in point-of-care we firmly our the underpinned the and goals largest by use and network have access to data-enabled insights real-world operational across platform financial ability in generation and of workflow US. best-in-class

making for patient and prescriber a across look positive years the base forward our to we pharma stakeholder such, impact come. to As

one earnings look alike our everyone, unified a omnichannel out Operator? We thank you. forward want our to investor shareholders, on platform customers, to our progress conferences. several reporting as employees, call continue Thank we and build next and on on partners and to solutions

Operator

you, Thank sir.

company's cautions forward-looking we conclude the statement regarding today's during includes statements I that harbor to call. important call, safe would made provide today's Before like

call may by amended to management make and of today's made should as Statements forward-looking not XXXX amended. as XXA XXXX of Act used definition These of Section the contain the during Securities Securities XXE Act the and statements Section statements within investment forward-looking decisions. of be

seeking expressions and the identify statements. only are possible anticipate, words to speak and estimate, forward-looking expect, that They date statements such similar made. The may

call market management's upcoming market the total penetration, expenses, investments, the and growth this technology, for include estimation in rest year. also margin, of announcements. opportunities, include statements gross addressable profitability, They the cash of acquisitions expectations regarding forward-looking revenue Such statements flow, operating size, growth,

update whether events inherently statements which to of revise new statements, information, obligation or subject predicted undertakes quantified. or and to cannot forward-looking company otherwise or are publicly forward-looking no The future any because uncertainties, risks of some be

effect include, differ actual to, which and to competition, risks statements are and are materially The could by of contemplated or results and forward-looking and government limited not events Future subject from regulation, the set those but material risks. other forth these to statements. underlying uncertainties forward-looking

statements ended SEC the company's to in XXst, uncertainties are quarter are forward-looking Form and affect This on on Form for could XX-K to at financial and the website company's on which business sec.gov. website the and included report subject annual the available XXXX. is results Risks December

Before later conference, to through Please replay call that a I via we release the press this would be to evening, like instructions year. will at running via only available for www.optimizerx.com. end this available starting remind today's today's for refer for everyone replay website webcast company's

joining Thank today's conference us you concludes This for call. today.

your disconnect You now may lines.

OptimizeRx (OPRX) 8 Mar 232022 Q4 Earnings call transcript